Literature DB >> 30705050

STING signalling protects against chronic pancreatitis by modulating Th17 response.

Qinglan Zhao1, Murli Manohar1, Yi Wei1, Stephen J Pandol2, Aida Habtezion1.   

Abstract

OBJECTIVE: Chronic pancreatitis (CP) is an inflammatory disease with progressive fibrosis leading to exocrine and endocrine dysfunction. Currently, there are no approved effective therapies for CP. Stimulator of interferon genes (STING) signalling is a key innate immune sensor of DNA. In this study, we evaluated the role of STING signalling in CP.
DESIGN: We used an experimental model of CP to test the effect of STING signalling in STING wild-type and knockout mice as well as bone marrow chimaeras (BMCs). STING was activated using a pharmacological agent. Since we found changes in Th17 cells, we used neutralising and control antibodies to determine the role of IL-17A. The effect of STING signalling was further explored in IL-17A generation and we examined the effect of IL-17A on pancreatic stellate cells (PSCs). Human pancreas from patients with CP and without CP were also stained for IL-17A.
RESULTS: STING activation decreased CP-associated pancreatic inflammation and fibrosis, whereas absence of STING led to worsening of the disease. BMCs showed that leucocytes play an important role in STING signalling-mediated amelioration of experimental CP. STING deletion was associated with increased Th17 cell infiltration in the pancreas, whereas STING agonist limited this Th17 response. Importantly, anti-IL-17A antibody treatment mitigated the severity of CP in the absence of STING signalling. STING deficiency promoted Th17 polarisation and PSCs express functional IL-17 receptor by upregulating fibrosis genes. Compared with tumour margins, pancreas from patients with CP had significant increase in IL-17A+ cells.
CONCLUSION: Unlike acute pancreatitis, STING activation is protective in CP. STING signalling is important in regulating adaptive immune responses by diminishing generation of IL-17A during CP and presents a novel therapeutic target for CP. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chronic pancreatitis; experimental pancreatitis; interleukins

Mesh:

Substances:

Year:  2019        PMID: 30705050      PMCID: PMC7069765          DOI: 10.1136/gutjnl-2018-317098

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.

Authors:  David R Wilson; Rupashree Sen; Joel C Sunshine; Drew M Pardoll; Jordan J Green; Young J Kim
Journal:  Nanomedicine       Date:  2017-11-07       Impact factor: 5.307

2.  5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential.

Authors:  Daniel Prantner; Darren J Perkins; Wendy Lai; Mark S Williams; Shruti Sharma; Katherine A Fitzgerald; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

3.  The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo.

Authors:  Kari Ann Shirey; Quan M Nhu; Kevin C Yim; Zachary J Roberts; John R Teijaro; Donna L Farber; Jorge C Blanco; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2010-11-17       Impact factor: 4.962

4.  STING agonists induce an innate antiviral immune response against hepatitis B virus.

Authors:  Fang Guo; Yanxing Han; Xuesen Zhao; Jianghua Wang; Fei Liu; Chunxiao Xu; Lai Wei; Jian-Dong Jiang; Timothy M Block; Ju-Tao Guo; Jinhong Chang
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

5.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

Review 6.  Chronic pancreatitis, pseudotumors and other tumor-like lesions.

Authors:  Günter Klöppel
Journal:  Mod Pathol       Date:  2007-02       Impact factor: 7.842

7.  Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA.

Authors:  Pu Gao; Manuel Ascano; Thomas Zillinger; Weiyi Wang; Peihong Dai; Artem A Serganov; Barbara L Gaffney; Stewart Shuman; Roger A Jones; Liang Deng; Gunther Hartmann; Winfried Barchet; Thomas Tuschl; Dinshaw J Patel
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

8.  Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.

Authors:  Florencia McAllister; Jennifer M Bailey; Janivette Alsina; Christopher J Nirschl; Rajni Sharma; Hongni Fan; Yanique Rattigan; Jeffrey C Roeser; Rachana H Lankapalli; Hao Zhang; Elizabeth M Jaffee; Charles G Drake; Franck Housseau; Anirban Maitra; Jay K Kolls; Cynthia L Sears; Drew M Pardoll; Steven D Leach
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743

9.  Improvement of the antitumor activity of intraperitoneally and orally administered 5,6-dimethylxanthenone-4-acetic acid by optimal scheduling.

Authors:  Liangli Zhao; Lai-Ming Ching; Philip Kestell; Bruce C Baguley
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

10.  Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis.

Authors:  Jing Xue; Vishal Sharma; Michael H Hsieh; Ajay Chawla; Ramachandran Murali; Stephen J Pandol; Aida Habtezion
Journal:  Nat Commun       Date:  2015-05-18       Impact factor: 14.919

View more
  18 in total

Review 1.  Chronic Pancreatitis and the Development of Pancreatic Cancer.

Authors:  Hemanth K Kandikattu; Sathisha U Venkateshaiah; Anil Mishra
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

2.  Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion.

Authors:  Jianjun Wu; Nicole Dobbs; Kun Yang; Nan Yan
Journal:  Immunity       Date:  2020-07-07       Impact factor: 31.745

3.  STING-induced regulatory B cells compromise NK function in cancer immunity.

Authors:  Sirui Li; Bhalchandra Mirlekar; Brandon M Johnson; W June Brickey; John A Wrobel; Na Yang; Dingka Song; Sarah Entwistle; Xianming Tan; Meng Deng; Ya Cui; Wei Li; Benjamin G Vincent; Michael Gale; Yuliya Pylayeva-Gupta; Jenny P-Y Ting
Journal:  Nature       Date:  2022-10-05       Impact factor: 69.504

4.  A novel multi-parametric analysis of non-invasive methods to assess animal distress during chronic pancreatitis.

Authors:  Ahmed Abdelrahman; Simone Kumstel; Xianbin Zhang; Marie Liebig; Edgar Heinz Uwe Wendt; Johanna Eichberg; Rupert Palme; Thomas Thum; Brigitte Vollmar; Dietmar Zechner
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

Review 5.  Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response.

Authors:  Dongshan Wan; Wei Jiang; Junwei Hao
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

6.  Protective Role of the Nucleic Acid Sensor STING in Pulmonary Fibrosis.

Authors:  Florence Savigny; Corinne Schricke; Norinne Lacerda-Queiroz; Mélanie Meda; Mégane Nascimento; Sarah Huot-Marchand; Felipe Da Gama Monteiro; Bernhard Ryffel; Aurélie Gombault; Marc Le Bert; Isabelle Couillin; Nicolas Riteau
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 7.  Circulating Lymphocyte Subsets Induce Secondary Infection in Acute Pancreatitis.

Authors:  Lili Ding; Yimin Yang; Hongxiang Li; Haijiao Wang; Pujun Gao
Journal:  Front Cell Infect Microbiol       Date:  2020-03-31       Impact factor: 5.293

Review 8.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

9.  Hic-5 deficiency protects cerulein-induced chronic pancreatitis via down-regulation of the NF-κB (p65)/IL-6 signalling pathway.

Authors:  Hao Chen; Peng Tan; Baolin Qian; Yichao Du; Ankang Wang; Hao Shi; Zhiwei Huang; Shiyao Huang; Tiancheng Liang; Wenguang Fu
Journal:  J Cell Mol Med       Date:  2019-12-03       Impact factor: 5.310

10.  Hic-5 is required for activation of pancreatic stellate cells and development of pancreatic fibrosis in chronic pancreatitis.

Authors:  Lin Gao; Xiao-Feng Lei; Aya Miyauchi; Masahito Noguchi; Tomokatsu Omoto; Shogo Haraguchi; Takuro Miyazaki; Akira Miyazaki; Joo-Ri Kim-Kaneyama
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.